Raymond James tells investors in a research note that it would take $40-$50 per share for private equity to take Acadia Healthcare (ACHC) private for a deal to make sense, but that anything over $50 “wouldn’t imply enough return” for it to make sense. The firm, which has a Strong Buy rating on Acadia shares, thinks it is becoming increasingly likely that a take private scenario occurs as the stock has floundered in the public market amid legal trouble and struggling fundamentals.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $37 from $48 at Mizuho
- Acadia Healthcare price target lowered to $44 from $66 at TD Cowen
- Acadia Healthcare price target lowered to $43 from $64 at RBC Capital
- Acadia Healthcare price target lowered to $65 from $70 at KeyBanc
- Strategic Growth Amidst Challenges: Whit Mayo’s Buy Rating on Acadia Healthcare
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue